Crystal for oral solid drug and oral solid drug for dysuria treatment containing the same
AssigneeKissei Pharmaceutical Co., Ltd.
InventorsEiji Tsuru, Michio Toda, Kazuma Hirata
Life of this patent
Estimating the term…
Abstract
A crystal for oral solid medicament comprised of indoline compound (KMD-3213) which exerts α1-adrenaline receptor blocking effect, is useful as a therapeutic agent for dysuria and is represented by the formula: (I) wherein in the powder X-ray diffraction pattern, the compound is characterized by main peaks of 5.5°±0.2°, 6.1°±0.2°, 9.8°±0.2°, 11.1°±0.2°, 12.2°±0.2°, 16.4°±0.2°, 19.7°±0.2° and 20.0°±0.2° as 2θ. There is further provided an oral solid medicament for dysuria treatment containing the crystal as an active ingredient.
Claims17
A crystal for an oral solid medicament of an indoline compound represented by the formula:
- which shows an X-ray powder diffraction pattern characterized by main peaks of 5.5°±0.2°, 6.1°±0.2°, 9.8°±0.2°, 11.1°±0.2°, 12.2°±0.2°, 16.4°±0.2°, 19.7°±0.2° and 20.0°±0.2° as 2θ.
Dependencies are inferred from the claim text.